Home » Authors » Jennifer Boggs

Articles by Jennifer Boggs

Accentia Files For $86M IPO To Fund Trials, Pay Off Debt

Feb. 15, 2005

By Jennifer Boggs

Amgen Confirms GDNF Halt In Parkinson's Development

Feb. 14, 2005

By Jennifer Boggs

Amgen Inc. will return to the drawing board with its drug for Parkinson's disease, GDNF, after further review of preclinical studies showed a risk of brain damage. (BioWorld Today)

Amgen Confirms GDNF Halt In Parkinson's Development

Feb. 14, 2005

By Jennifer Boggs

Amgen Inc. will return to the drawing board with its drug for Parkinson's disease, GDNF, after further review of preclinical studies showed a risk of brain damage. (BioWorld Today)

Vical Sets SPA, Readies For Allovectin-7 Phase III Trial

Feb. 11, 2005

By Jennifer Boggs

Vical Sets SPA, Readies For Allovectin-7 Phase III Trial

Feb. 11, 2005

By Jennifer Boggs

MediciNova Prices Japanese IPO, Gets $107M For Pipeline

Feb. 10, 2005

By Jennifer Boggs

MediciNova Prices Japanese IPO, Gets $107M For Pipeline

Feb. 10, 2005

By Jennifer Boggs

Tercica Gets $48M, Awaits FDA Approval For Growth Factor Drug

Feb. 9, 2005

By Jennifer Boggs

Tercica Gets $48M, Awaits FDA Approval For Growth Factor Drug

Feb. 9, 2005

By Jennifer Boggs

Vicuron Reports Positive Phase III Results, Plans Third-Quarter NDA

Feb. 8, 2005

By Jennifer Boggs

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 2, 2026.
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...
AND-017 increases RBC and hemoglobin in sickle cell disease
BioWorld Science
Sickle cell disease (SCD) is an inherited hemoglobinopathy caused by a mutation in the gene encoding β-globin that results in hemoglobin S polymerization, red...